Product Information
METOCLOPRAMIDE 5 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.0354 per EA under NDC 62559029501. Its NADAC has been published 198 times since Nov 9, 2022.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559029501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017854FDA Approved
Before 1982
TE Code
AB
On Market Since
12/13/2021
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 5 MG TABLET has been published 198 times since Nov 9, 2022, and over the history we have for it it has declined 20.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0354 per EA |
|---|---|
| All-time high | $0.0455 (Dec 14, 2022) |
| All-time low | $0.0354 (Aug 19, 2026) |
| 52-week high | $0.0433 |
| 52-week low | $0.0354 |
| Median price | $0.0428 |
| Average price | $0.0419 |
| Largest weekly change | -18.5% (Apr 17, 2024) |
| Weeks tracked | 198 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 5 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.0354 per EA (NDC 62559029501), effective Aug 19, 2026.
How has the price of METOCLOPRAMIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 5 MG TABLET has declined 20.7%. It has been tracked across 198 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 5 MG TABLET?
Since Nov 9, 2022, the NADAC for METOCLOPRAMIDE 5 MG TABLET has ranged from a low of $0.0354 (Aug 19, 2026) to a high of $0.0455 (Dec 14, 2022), with a median of $0.0428 per EA.
Are there cheaper alternatives to METOCLOPRAMIDE 5 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOCLOPRAMIDE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METOCLOPRAMIDE 5 MG TABLET?
METOCLOPRAMIDE 5 MG TABLET (NDC 62559029501) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.